Comments
Vadodara-based Alembic Pharmaceuticals Ltd has posted a net profit of Rs 102 crore for the first quarter ended June 30, 2016, showing 45 per cent rise over Rs 70.17 crore reported in the corresponding period last year.
Net sales increased by 25 per cent to Rs 736 crore.
Commenting on the results, Pranav Amin, Managing Director, said: "We continue to invest in R&D for future growth. Alembic USA was successfully established and has launched 23 products in the market."
The company has reported 72 per cent growth in international formulations business to Rs 308 crore. Whereas the India branded business grew 6 per cent to Rs 277.74 crore.
Alembic Pharmaceuticals shares were trading up by 2.5 per cent at Rs 628.05 on the National Stock Exchange.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.